F
Flavia Belloni
Researcher at Catholic University of the Sacred Heart
Publications - 29
Citations - 863
Flavia Belloni is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 14, co-authored 29 publications receiving 672 citations. Previous affiliations of Flavia Belloni include The Catholic University of America.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Marco Valgimigli,Enrico Frigoli,Sergio Leonardi,Pascal Vranckx,Martina Rothenbühler,Matteo Tebaldi,Ferdinando Varbella,Paolo Calabrò,Stefano Garducci,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Maurizio Ferrario,Ugo Limbruno,Roberto Garbo,Paolo Sganzerla,Filippo Russo,Marco Stefano Nazzaro,Alessandro Lupi,Bernardo Cortese,Arturo Ausiello,Salvatore Ierna,Giovanni Esposito,Giuseppe Ferrante,Andrea Santarelli,Gennaro Sardella,Nicoletta De Cesare,Paolo Tosi,Arnoud W J van 't Hof,Elmir Omerovic,Salvatore Brugaletta,Stephan Windecker,Dik Heg,Peter Jüni,Gianluca Campo,Lucia Uguccioni,Corrado Tamburino,Patrizia Presbitero,Dennis Zavalloni-Parenti,Fabio Ferrari,Roberto Ceravolo,Fabio Tarantino,Giampaolo Pasquetto,Gavino Casu,Stefano Mameli,Maria Letizia Stochino,Pietro Mazzarotto,Alberto Cremonesi,Francesco Saia,Giovanni Saccone,Fabio Abate,Andrea Picchi,Roberto Violini,Salvatore Colangelo,Giacomo Boccuzzi,Vincenzo Guiducci,Carlo Vigna,Antonio Zingarelli,Andrea Gagnor,Tiziana Zaro,Simone Tresoldi,Pietro Vandoni,Marco Contarini,Armando Liso,Dellavalle A,Salvatore Curello,Fabio Mangiacapra,Rosario Evola,Cataldo Palmieri,Camillo Falcone,Francesco Liistro,Manuela Creaco,Antonio Colombo,Alaide Chieffo,Andrea Perkan,Stefano De Servi,Dionigi Fischetti,Stefano Rigattieri,Alessandro Sciahbasi,Edoardo Pucci,Enrico Romagnoli,Claudio Moretti,Luciano Moretti,Raffaele De Caterina,Marcello Caputo,Marco Zimmarino,Ezio Bramucci,Emilio Di Lorenzo,Maurizio Turturo,Roberto Bonmassari,Carlo Penzo,Bruno Loi,Ciro Mauro,Anna Sonia Petronio,Gabriele Gabrielli,Antonio Micari,Flavia Belloni,Francesco Amico,Marco Comeglio,Claudio Fresco,Isala Klinieken,Nicolas M. Van Mieghem,Roberto Diletti,Evelyn Regar,Manel Sabaté,José Francisco Díaz Fernández,Vicente Mainar,José M. de la Torre Hernández +107 more
TL;DR: The prespecified final 1-year outcomes of the MATRIX programme, designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin with optional glycoprotein IIb/IIIa inhibitors in patients with the whole spectrum of acute coronary syndrome undergoing invasive management, are described.
Journal ArticleDOI
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
Giuseppe Andò,Bernardo Cortese,Filippo Russo,Martina Rothenbühler,Enrico Frigoli,Giuseppe Gargiulo,Carlo Briguori,Pascal Vranckx,Sergio Leonardi,Vincenzo Guiducci,Flavia Belloni,Fabio Ferrari,José M. de la Torre Hernández,Salvatore Curello,Francesco Liistro,Andrea Perkan,Stefano De Servi,Gavino Casu,Dellavalle A,Dionigi Fischetti,Antonio Micari,Bruno Loi,Fabio Mangiacapra,Nunzio Russo,Fabio Tarantino,Francesco Saia,Dik Heg,Stephan Windecker,Peter Jüni,Marco Valgimigli,Matrix Investigators +30 more
TL;DR: In ACS patients who underwent invasive management, RA was associated with a reduced risk of AKI compared with FA, and Stratified analyses suggested greater benefit with RA than FA in patients at greater risk for AKI.
Journal ArticleDOI
Eosinophil cationic protein: A new biomarker of coronary atherosclerosis
Giampaolo Niccoli,Giuseppe Ferrante,Nicola Cosentino,Micaela Conte,Flavia Belloni,Marcello Marino,Marco Bacà,Rocco A. Montone,Vito Sabato,Domenico Schiavino,Giampiero Patriarca,Filippo Crea +11 more
TL;DR: The study shows that ECP is a marker of CAD and that different inflammatory biomarkers reflect different phases of atherosclerotic plaque evolution.
Journal ArticleDOI
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Giuseppe Tarantini,Marco Mojoli,Ferdinando Varbella,Roberto Caporale,Stefano Rigattieri,Giuseppe Andò,Plinio Cirillo,Simona Pierini,Andrea Santarelli,Paolo Sganzerla,Luisa Cacciavillani,Luciano Babuin,Nicoletta De Cesare,Ugo Limbruno,Alberto Massoni,Andrea Rognoni,Daniela Pavan,Flavia Belloni,Carlo Cernetti,Luca Favero,Francesco Saia,Luca Nai Fovino,Giulia Masiero,Loris Roncon,Valeria Gasparetto,Marco Ferlini,Federico Ronco,Roberta Rossini,Paolo Canova,Daniela Trabattoni,A. Russo,Vincenzo Guiducci,Carlo Penzo,Fabio Tarantino,Ciro Mauro,Elena Corrada,Giovanni Esposito,Alfredo Marchese,Sergio Berti,Matteo Martinato,Danila Azzolina,Dario Gregori,Dominick J. Angiolillo,Giuseppe Musumeci,Dubius Investigators +44 more
TL;DR: Downstream and upstream oral P2Y12 inhibitors administration strategies were associated with low incidence of ischemic and bleeding events and minimal numerical difference of event rates between treatment groups, suggesting the unlikelihood of enhanced efficacy of one strategy over the other.
Journal ArticleDOI
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents
Giampaolo Niccoli,Domenico Schiavino,Flavia Belloni,Giuseppe Ferrante,Giuseppe La Torre,Micaela Conte,Nicola Cosentino,Rocco A. Montone,Vito Sabato,Francesco Burzotta,Carlo Trani,Antonio Maria Leone,Italo Porto,Maurizio Pieroni,Giampiero Patriarca,Filippo Crea +15 more
TL;DR: This study shows for the first time an association between baseline ECP levels and the occurrence of MACEs in patients undergoing implantation of DES, and further studies are warranted to establish whether in this setting ECP is a risk marker or plays a contributory pathogenetic role.